BNP Paribas Financial Markets
INZY

BNP Paribas Financial Markets’s Inozyme Pharma INZY Stock Holding History

BNP Paribas Financial Markets’s Portfolio INZY Stock Details INZY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,505
Closed -$6.02K – 5661
2025
Q2 		$6.02K Sell
1,505
-2,157
-59% -$5.34K ﹤0.01% 4938
2025
Q1 		$3.33K Sell
3,662
-3,018
-45% -$4.18K ﹤0.01% 4917
2024
Q4 		$18.5K Buy
+6,680
New +$25.4K ﹤0.01% 4741

BNP Paribas Financial Markets's INZY Position: Q3 2025 in Review

BNP Paribas Financial Markets sold out of Inozyme Pharma (INZY) in Q3 2025, closing a stake of 1,505 shares — an estimated $6.02K sold.

BNP Paribas Financial Markets first reported a position in INZY in Q4 2024 and held it in 3 quarters. The position peaked at $18.5K in Q4 2024. 0 funds tracked by Wall St. Rank hold INZY as of Q3 2025.

  • BNP Paribas Financial Markets reported no remaining Inozyme Pharma position as of Q3 2025 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 1,505 Inozyme Pharma shares in Q3 2025, an estimated $6.02K.
  • BNP Paribas Financial Markets first reported a position in Inozyme Pharma in Q4 2024 and held it in 3 quarters.
  • BNP Paribas Financial Markets's Inozyme Pharma position peaked at $18.5K in Q4 2024.
  • 0 funds tracked by Wall St. Rank held Inozyme Pharma as of Q3 2025.

Based on BNP Paribas Financial Markets's 13F filing for Q3 2025, filed 13 Nov 2025.